MEGAN NIEMIEC: Open Payments
NPI 1245797364 · NEW LENOX, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,553 in 129 payments from 20 companies in 2025. Trend: 2023 $1,830 · 2024 $1,408 · 2025 $2,553
Food & beverage: $2,293Education: $260
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $419 |
| Novartis Pharmaceuticals Corporation | 14 | $318 |
| ABBVIE INC. | 15 | $288 |
| Arcutis Biotherapeutics, Inc. | 18 | $261 |
| UCB, Inc. | 8 | $244 |
| Lilly USA, LLC | 7 | $155 |
| GENZYME CORPORATION | 4 | $144 |
| Amgen Inc. | 7 | $144 |
| MAYNE PHARMA COMMERCIAL LLC | 23 | $127 |
| Incyte Corporation | 3 | $86 |
Products named: TREMFYA, Zoryve, Bimzelx, COSENTYX, DUPIXENT, SKYRIZI, OTEZLA, RINVOQ.
Industry payments across IL — which companies pay providers there.
